✦ LIBER ✦

Molecular mechanisms underlying human synovial sarcoma development

✍ Scribed by Nuno R. dos Santos; Diederik R.H. de Bruijn; Ad Geurts van Kessel

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 324 KB
Volume: 30
Category: Article
ISSN: 1045-2257
DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1056>3.0.co;2-g

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Morphogenesis and molecular mechanisms i

Morphogenesis and molecular mechanisms involved in human kidney development

✍ Gavino Faa; Clara Gerosa; Daniela Fanni; Giudo Monga; Marco Zaffanello; Peter Va 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 746 KB

## Abstract The development of the human kidney is a complex process that requires interactions between epithelial and mesenchymal cells, eventually leading to the coordinated growth and differentiation of multiple highly specialized stromal, vascular, and epithelial cell types. The application of

Molecular Mechanisms Underlying Renal Ac

Molecular Mechanisms Underlying Renal Accumulation of Aminoglycoside Antibiotics and Mechanism-Based Approach for Developing Nonnephrotoxic Aminoglycoside Therapy

✍ Junya Nagai 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB

Molecular mechanisms underlying the syne

Molecular mechanisms underlying the synergistic induction of CXCL10 by LPS and IFN-γ in human neutrophils

✍ Nicola Tamassia; Federica Calzetti; Thornin Ear; Alexandre Cloutier; Sara Gasper 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

Molecular mechanisms underlying the inhi

Molecular mechanisms underlying the inhibition of IFN-γ-induced, STAT1-mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRs

✍ Na Li; Rebecca C. Salter; Dr. Dipak P. Ramji 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

## Abstract PPARs and LXRs are ligand‐activated transcription factors that are emerging as promising therapeutic targets for limiting atherosclerosis, an inflammatory disorder orchestrated by cytokines. The potent anti‐atherogenic actions of these nuclear receptors involve the regulation of glucose